文献速递新生儿儿童呼吸

预防早产儿支气管肺发育不良的干预措施:系统综述与荟萃分析的伞状综述

Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses.
PubMed 文献 · JAMA Pediatr · 2022-01-01

该伞状综述纳入154篇系统综述,评估多种预防早产儿支气管肺发育不良(BPD)的干预措施。高质量系统综述的高确定性证据表明,产房持续气道正压通气、早期选择性肺表面活性物质、早期吸入糖皮质激素、早期全身性氢化可的松、避免气管插管联合微创肺表面活性物质给药以及容量目标通气可降低36周校正胎龄时BPD或死亡风险。中等至高等确定性证据显示吸入一氧化氮、较低血氧饱和度目标(85%-89%)和维生素A补充与BPD风险降低相关,但可能增加死亡率。

要点

  • 产房持续气道正压通气、早期选择性肺表面活性物质联合微创给药可降低BPD或死亡风险
  • 早期吸入糖皮质激素、早期全身性氢化可的松、容量目标通气也降低BPD或死亡风险
  • 吸入一氧化氮、低血氧饱和度目标(85%-89%)和维生素A补充可能增加死亡率

核心结论

  • 多模式干预(产房持续气道正压通气、早期选择性肺表面活性物质联合微创给药、高危儿早期氢化可的松预防、吸入糖皮质激素、容量目标通气)可能降低需要侵入性通气的早产儿36周校正胎龄时BPD或死亡复合风险。
  • 吸入一氧化氮、较低血氧饱和度目标(85%-89%)和维生素A补充与BPD风险降低相关,但可能增加死亡率。

研究设计与样本

  • 伞状综述,检索MEDLINE、Cochrane Central Register of Controlled Trials、EMBASE和Web of Science自建库至2020年11月9日。
  • 纳入以BPD为结局的早产儿随机临床试验的荟萃分析,共纳入154篇系统综述,评估251项比较,其中110篇(71.4%)为高质量系统综述。
  • 采用AMSTAR 2评估系统综述质量,采用GRADE评估证据确定性。

主要发现

  • 产房持续气道正压通气对比插管(伴或不伴常规肺表面活性物质)与36周校正胎龄时BPD或死亡风险降低相关(RR 0.80,95%CI 0.68-0.94),证据确定性高。
  • 早期选择性肺表面活性物质对比延迟选择性肺表面活性物质与BPD或死亡风险降低相关(RR 0.83,95%CI 0.75-0.91),证据确定性高。
  • 早期吸入糖皮质激素与BPD或死亡风险降低相关(RR 0.86,95%CI 0.75-0.99),证据确定性高。
  • 早期全身性氢化可的松与BPD或死亡风险降低相关(RR 0.90,95%CI 0.82-0.99),证据确定性高。
  • 避免气管插管联合产房持续气道正压通气及微创肺表面活性物质给药与BPD或死亡风险降低相关(RR 0.90,95%CI 0.82-0.99),证据确定性高;容量目标通气对比压力限制通气与BPD或死亡风险降低相关(RR 0.73,95%CI 0.59-0.89),证据确定性高。

关键数值与推荐

  • 主要结局为36周校正胎龄时BPD或死亡,以及36周校正胎龄时BPD。
  • 高质量系统综述的高确定性证据支持产房持续气道正压通气(RR 0.80,95%CI 0.68-0.94)、早期选择性肺表面活性物质(RR 0.83,95%CI 0.75-0.91)、早期吸入糖皮质激素(RR 0.86,95%CI 0.75-0.99)、早期全身性氢化可的松(RR 0.90,95%CI 0.82-0.99)、避免气管插管联合微创肺表面活性物质给药(RR 0.90,95%CI 0.82-0.99)和容量目标通气(RR 0.73,95%CI 0.59-0.89)降低BPD或死亡风险。
  • 中等至高等确定性证据显示吸入一氧化氮、较低血氧饱和度目标(85%-89%)和维生素A补充与36周校正胎龄时BPD风险降低相关,但与BPD或死亡复合结局无关,提示可能增加死亡率。

临床怎么用

  • 对早产儿可考虑产房持续气道正压通气、早期选择性肺表面活性物质联合微创给药、容量目标通气等有高确定性证据支持的干预以降低BPD或死亡风险。
  • 对高危早产儿可考虑早期全身性氢化可的松预防或早期吸入糖皮质激素,但需权衡获益与风险。
  • 使用吸入一氧化氮、较低血氧饱和度目标(85%-89%)或维生素A补充时需警惕可能增加死亡率。

局限性

  • 检索截止至2020年11月9日,未纳入此后发表的系统综述。
  • 部分干预措施的证据确定性为中等至高等,且与复合结局的关系不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Bronchopulmonary dysplasia (BPD) has multifactorial etiology and long-term adverse consequences. An umbrella review enables the evaluation of multiple proposed interventions for the prevention of BPD. OBJECTIVE: To summarize and assess the certainty of evidence of interventions proposed to decrease the risk of BPD from published systematic reviews. DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, and Web of Science were searched from inception until November 9, 2020. STUDY SELECTION: Meta-analyses of randomized clinical trials comparing interventions in preterm neonates that included BPD as an outcome. DATA EXTRACTION AND SYNTHESIS: Data extraction was performed in duplicate. Quality of systematic reviews was evaluated using Assessment of Multiple Systematic Reviews version 2, and certainty of evidence was assessed using Grading of Recommendation, Assessment, Development, and Evaluation. MAIN OUTCOMES AND MEASURES: (1) BPD or mortality at 36 weeks' postmenstrual age (PMA) and (2) BPD at 36 weeks' PMA. RESULTS: A total of 154 systematic reviews evaluating 251 comparisons were included, of which 110 (71.4%) were high-quality systematic reviews. High certainty of evidence from high-quality systematic reviews indicated that delivery room continuous positive airway pressure compared with intubation with or without routine surfactant (relative risk [RR], 0.80 [95% CI, 0.68-0.94]), early selective surfactant compared with delayed selective surfactant (RR, 0.83 [95% CI, 0.75-0.91]), early inhaled corticosteroids (RR, 0.86 [95% CI, 0.75-0.99]), early systemic hydrocortisone (RR, 0.90 [95% CI, 0.82-0.99]), avoiding endotracheal tube placement with delivery room continuous positive airway pressure and use of less invasive surfactant administration (RR, 0.90 [95% CI, 0.82-0.99]), and volume-targeted compared with pressure-limited ventilation (RR, 0.73 [95% CI, 0.59-0.89]) were associated with decreased risk of BPD or mortality at 36 weeks' PMA. Moderate to high certainty of evidence showed that inhaled nitric oxide, lower saturation targets (85%-89%), and vitamin A supplementation are associated with decreased risk of BPD at 36 weeks' PMA but not the competing outcome of BPD or mortality, indicating they may be associated with increased mortality. CONCLUSIONS AND RELEVANCE: A multipronged approach of delivery room continuous positive airway pressure, early selective surfactant administration with less invasive surfactant administration, early hydrocortisone prophylaxis in high-risk neonates, inhaled corticosteroids, and volume-targeted ventilation for preterm neonates requiring invasive ventilation may decrease the combined risk of BPD or mortality at 36 weeks' PMA.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Abiramalatha T, Ramaswamy VV, Bandyopadhyay T, et al. Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses. JAMA Pediatr. 2022. PMID: 35226067. doi:10.1001/jamapediatrics.2021.6619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。